Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...

Shares of Sun Pharmaceutical Industries Ltd. are trading 2.4% lower on Thursday, December 18, after the US Food and Drug ...

Sun Pharmaceutical Industries Ltd announced that its Baska manufacturing facility has been classified as Official Action ...

Sun Pharma''s Baska facility in Gujarat receives OAI classification from USFDA after inspection. What does this mean for the ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 advanced 1.16% to 1,806.90 Indian rupees Thursday, on what proved to be ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

In a dramatic change to Australian patent law, Australia's Full Federal Court has just held that patents for pharmaceutical formulations are not eligible for patent term extensions ( PTE ): Otsuka ...

A trio of Indian drugmakers—Alembic Pharmaceuticals, Sun Pharmaceutical and Glenmark Pharmaceuticals—issued separate voluntary U.S. drug recalls in recent weeks due to either the presence of ...

Ascroft succeeds Abhay Gandhi. According to a June 25 hiring announcement from the the India-based parent company Gandhi, “played a pivotal role in the growth of the Sun Pharma North America business.

SPARC: The stock jumped 20 per cent to touch its upper price band of Rs 161.10, although it remains down 19.73 per cent on a year-to-date (YTD) basis.

The Delhi High Court on Wednesday recorded Sun Pharmaceutical Industries Ltd.'s assurance that it will not sell its ...

Sun Pharma informed the stock exchanges that the board of directors of its subsidiary Sun Pharma Laboratories approved the investment proposal of ₹3,000 crore to set up a greenfield formulations ...